Unknown

Dataset Information

0

Polyhistidine facilitates direct membrane translocation of cell-penetrating peptides into cells.

ABSTRACT: The bovine lactoferricin L6 (RRWQWR) has been previously identified as a novel cell-penetrating peptide (CPP) that is able to efficiently internalize into human cells. L6 interacts with quantum dots (QDs) noncovalently to generate stable L6/QD complexes that enter cells by endocytosis. In this study, we demonstrate a modified L6 (HL6; CHHHHHRRWQWRHHHHHC), in which short polyhistidine peptides are introduced into both flanks of L6, has enhanced cell-penetrating ability in human bronchoalveolar carcinoma A549 cells. The mechanism of cellular uptake of HL6/QD complexes is primarily direct membrane translocation rather than endocytosis. Dimethyl sulfoxide (DMSO), but not pyrenebutyrate (PB), ethanol, oleic acid, or 1,2-benzisothiazol-3(2?H)-one (BIT), slightly enhances HL6-mediated protein transduction efficiency. Neither HL6 nor HL6/QD complexes are cytotoxic to A549 or HeLa cells. These results indicate that HL6 could be a more efficient drug carrier than L6 for biomedical as well as biotechnological applications, and that the function of polyhistidine peptides is critical to CPP-mediated protein transduction.

SUBMITTER: Lee HJ 

PROVIDER: S-EPMC6599048 | biostudies-literature | 2019 Jun

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Polyhistidine facilitates direct membrane translocation of cell-penetrating peptides into cells.

Lee Han-Jung HJ   Huang Yue-Wern YW   Chiou Shiow-Her SH   Aronstam Robert S RS  

Scientific reports 20190628 1

The bovine lactoferricin L6 (RRWQWR) has been previously identified as a novel cell-penetrating peptide (CPP) that is able to efficiently internalize into human cells. L6 interacts with quantum dots (QDs) noncovalently to generate stable L6/QD complexes that enter cells by endocytosis. In this study, we demonstrate a modified L6 (HL6; CHHHHHRRWQWRHHHHHC), in which short polyhistidine peptides are introduced into both flanks of L6, has enhanced cell-penetrating ability in human bronchoalveolar ca  ...[more]

Similar Datasets

Unknown Translocation of cell-penetrating peptides into Candida fungal pathogens.
| S-EPMC5563134 | biostudies-literature
Unknown Key Process and Factors Controlling the Direct Translocation of Cell-Penetrating Peptide through Bio-Membrane.
| S-EPMC7432884 | biostudies-literature
Unknown Cholesterol re-organisation and lipid de-packing by arginine-rich cell penetrating peptides: Role in membrane translocation.
| S-EPMC6343925 | biostudies-literature
Unknown Arginine-rich peptides destabilize the plasma membrane, consistent with a pore formation translocation mechanism of cell-penetrating peptides.
| S-EPMC2756373 | biostudies-other
Unknown Dynamic measurements of membrane insertion potential of synthetic cell penetrating peptides.
| S-EPMC3918496 | biostudies-literature
Unknown Plasma membrane damage limits cytoplasmic delivery by conventional cell penetrating peptides.
| S-EPMC11371239 | biostudies-literature
Unknown Attachment of cell-binding ligands to arginine-rich cell-penetrating peptides enables cytosolic translocation of complexed siRNA.
| S-EPMC4320807 | biostudies-literature
Unknown Identification and characterization of a new family of cell-penetrating peptides: cyclic cell-penetrating peptides.
| S-EPMC3196123 | biostudies-literature
Unknown Arginine-Rich Cell-Penetrating Peptides Induce Lipid Rearrangements for Their Active Translocation across Laterally Heterogeneous Membranes.
| S-EPMC11348069 | biostudies-literature
Unknown Selective Moonlighting Cell-Penetrating Peptides.
| S-EPMC8400200 | biostudies-literature